13 insiders reported 60 Form 4 transactions for Anika Therapeutics, Inc. (ANIK) over the past 18 months (most recent 2026-06-23). Recent activity: CONLEY SHERYL L (Director) Buy 10,402 shares, HENNEMAN JOHN B III (Director) Buy 10,402 shares, Capper Joseph H (Director) Buy 10,402 shares, Richard Stephen (Director) Buy 10,402 shares, Fischetti Gary P (Director) Buy 10,402 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | CONLEY SHERYL L | Director | Buy | 10,402 | $0 |
| 2026-06-23 | HENNEMAN JOHN B III | Director | Buy | 10,402 | $0 |
| 2026-06-23 | Capper Joseph H | Director | Buy | 10,402 | $0 |
| 2026-06-23 | Richard Stephen | Director | Buy | 10,402 | $0 |
| 2026-06-23 | Fischetti Gary P | Director | Buy | 10,402 | $0 |
| 2026-06-05 | Griffin Stephen D. | President and CEO | Buy | 12,840 | $0 |
| 2026-06-05 | Griffin Stephen D. | President and CEO | Sell | 3,769 | $54,311 |
| 2026-04-30 | Griffin Stephen D. | President and CEO | Buy | 12,200 | $149,881 |
| 2026-03-17 | McLeod Ian | SVP, CAO & Treasurer | Buy | 1,161 | $0 |
| 2026-03-17 | Griffin Stephen D. | President and CEO | Buy | 6,412 | $0 |
| 2026-03-17 | Griffin Stephen D. | President and CEO | Sell | 5,944 | $84,405 |
| 2026-03-17 | McLeod Ian | SVP, CAO & Treasurer | Buy | 3,774 | $0 |
| 2026-03-17 | Griffin Stephen D. | President and CEO | Buy | 12,824 | $0 |
| 2026-03-17 | McLeod Ian | SVP, CAO & Treasurer | Sell | 1,449 | $20,576 |
| 2026-03-17 | McLeod Ian | SVP, CAO & Treasurer | Buy | 2,658 | $0 |
| 2026-03-17 | McLeod Ian | SVP, CAO & Treasurer | Sell | 781 | $11,090 |
| 2026-03-17 | Colleran David | EVP, General Counsel, Corp Sec | Buy | 9,388 | $0 |
| 2026-03-17 | Colleran David | EVP, General Counsel, Corp Sec | Buy | 4,694 | $0 |
| 2026-03-17 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 4,168 | $59,186 |
| 2026-03-17 | Colleran David | EVP, General Counsel, Corp Sec | Buy | 6,449 | $0 |
| 2026-03-17 | Blanchard Cheryl R | Director | Buy | 25,131 | $0 |
| 2026-03-17 | Blanchard Cheryl R | Director | Buy | 24,519 | $0 |
| 2026-03-17 | Blanchard Cheryl R | Director | Buy | 24,520 | $0 |
| 2026-03-17 | Blanchard Cheryl R | Director | Sell | 14,728 | $209,138 |
| 2026-03-17 | Colleran David | EVP, General Counsel, Corp Sec | Sell | 1,893 | $26,881 |
Source: SEC Form 4 filings · as of 2026-06-23